WAYNE, Pa. (AP) _ Egalet Corp. (EGLTQ) on Monday reported a loss of $51.2 million in its third quarter.
The Wayne, Pennsylvania-based company said it had a loss of 93 cents per share. Losses, adjusted for one-time gains and costs, were 75 cents per share.
The pain medicine maker posted revenue of $8.2 million in the period.
WAYNE, Pa. (AP) _ Egalet Corp. (EGLT) on Wednesday reported a loss of $12 million in its second quarter.
The Wayne, Pennsylvania-based company said it had a loss of 22 cents per share. Losses, adjusted for non-recurring costs, were 17 cents per share.
The pain medicine maker posted revenue of $7.4 million in the period.
- Business WireAdare Acquires Egalet’s Proprietary “ParvuletTM” Technology PlatformApril 15, 2019
- Globe NewswireNew Research Coverage Highlights Argos Therapeutics, Triumph Group, Rigel Pharmaceuticals, Egalet, Hertz Global, and ACADIA Pharmaceuticals — Consolidated Revenues, Company Growth, and Expectations for 2018August 31, 2018
- Globe NewswireMarket Trends Toward New Normal in Egalet, PPG Industries, Synergy Pharmaceuticals, Equity Residential, Array BioPharma, and Holly Energy Partners — Emerging Consolidated Expectations, Analyst RatingsJuly 27, 2018
- Globe NewswireReport: Developing Opportunities within Integer, Sykes Enterprises, Protagonist Therapeutics, Egalet, Watsco, and Extra Space Storage — Future Expectations, Projections Moving into 2018May 22, 2018